A novel mutation (F227L) arises in the reverse transcriptase of human immunodeficiency virus type 1 on dose-escalating treatment of HIV type 1-infected cell cultures with the nonnucleoside reverse transcriptase inhibitor thiocarboxanilide UC-781. (AIDS research and human retroviruses, 1998)

(untitled) - Balzarini, J; Pelemans, H; Esnouf, R; De Clercq, E